ATE523495T1 - Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente - Google Patents

Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente

Info

Publication number
ATE523495T1
ATE523495T1 AT06762612T AT06762612T ATE523495T1 AT E523495 T1 ATE523495 T1 AT E523495T1 AT 06762612 T AT06762612 T AT 06762612T AT 06762612 T AT06762612 T AT 06762612T AT E523495 T1 ATE523495 T1 AT E523495T1
Authority
AT
Austria
Prior art keywords
preparation
medications
substituted pyrazoline
pyrazoline compounds
compounds
Prior art date
Application number
AT06762612T
Other languages
English (en)
Inventor
Altisen Maria Rosa Cuberes
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35311564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE523495(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE523495T1 publication Critical patent/ATE523495T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
AT06762612T 2005-07-15 2006-07-15 Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente ATE523495T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05384005A EP1757587A1 (de) 2005-07-15 2005-07-15 Substituierte Pyrazolinderivate, ihre Herstellung und Verwendung als Arzneimittel
US70548105P 2005-08-05 2005-08-05
PCT/EP2006/006969 WO2007009695A1 (en) 2005-07-15 2006-07-15 Substituted pyrazoline compounds, their preparation and use as medicaments

Publications (1)

Publication Number Publication Date
ATE523495T1 true ATE523495T1 (de) 2011-09-15

Family

ID=35311564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06762612T ATE523495T1 (de) 2005-07-15 2006-07-15 Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente

Country Status (7)

Country Link
US (1) US20070015810A1 (de)
EP (2) EP1757587A1 (de)
AT (1) ATE523495T1 (de)
ES (1) ES2372307T3 (de)
PE (1) PE20070246A1 (de)
TW (1) TW200745043A (de)
WO (1) WO2007009695A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
EP1743892A1 (de) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituierte Pyrazolin Verbindungen, deren Herstellung und Verwendung als Medikament
CA2666193A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2042175A1 (de) * 2007-09-21 2009-04-01 Laboratorios del Dr. Esteve S.A. Dosierungsschemata von CB1-Rezeptor-Liganden für die Behandlung von Fettleibigkeit
WO2009097995A1 (de) * 2008-02-07 2009-08-13 Sanofi-Aventis Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2310372B1 (de) 2008-07-09 2012-05-23 Sanofi Heterocyclische Verbindungen, Verfahren zu ihrer Herstellung, Arzneimitteln mit diesen Verbindungen und ihre Verwendung
EP2151234A1 (de) * 2008-07-28 2010-02-10 Laboratorios Del. Dr. Esteve, S.A. Pharmazeutische Formulierung mit einer CB1-Rezeptorverbindung in einer festen Lösung und/oder festen Dispersion
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
EP2470552B1 (de) 2009-08-26 2013-11-13 Sanofi Neuartige kristalline heteroaromatische Fluorglycosidhydrate, Pharmazeutika, die diese Verbindungen umfassen, und deren Verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
JP2017028024A (ja) * 2015-07-17 2017-02-02 富士通株式会社 部品搭載基板、部品内蔵基板、部品搭載基板の製造方法および部品内蔵基板の製造方法
WO2020237043A1 (en) * 2019-05-22 2020-11-26 President And Fellows Of Harvard College Human tactile prepulse inhibition assay

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
FR2742147B1 (fr) * 1995-12-06 1998-02-27 Esteve Labor Dr Procede de separation de carbinols
US20020156104A1 (en) * 1997-06-13 2002-10-24 Jerry L. Adams Novel pyrazole and pyrazoline substituted compounds
ES2130079B1 (es) * 1997-07-10 2000-01-16 Esteve Labor Dr Resolucion de aminas
ES2130083B1 (es) * 1997-08-04 2000-01-16 Esteve Labor Dr Procedimiento para la obtencion de los enantiomeros de cizolirtina.
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137138B1 (es) * 1998-05-29 2000-09-16 Esteve Labor Dr Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
EP1177188B1 (de) * 1999-05-12 2005-10-12 Ortho-McNeil Pharmaceutical, Inc. Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
ATE349439T1 (de) * 2000-06-22 2007-01-15 Pharmos Corp Neue nicht psychotropische cannabinoide
HUP0303070A2 (hu) * 2000-08-01 2003-12-29 Ono Pharmaceutical Co., Ltd. 3,4-Dihidro-izokinolin-származékok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
CN100366614C (zh) * 2001-03-22 2008-02-06 索尔瓦药物有限公司 具有cb1－拮抗活性的4,5－二氢－1h－吡唑衍生物
ES2183720B1 (es) * 2001-06-18 2004-01-16 Esteve Labor Dr Procedimiento para la preparacion de derivados de 1,5-diaril-3-trifluorometil-delta2-pirazolinas racemicas y enantiomericamente puras.
ES2180449B1 (es) * 2001-07-06 2004-01-16 Esteve Labor Dr Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
US6509367B1 (en) * 2001-09-22 2003-01-21 Virginia Commonwealth University Pyrazole cannabinoid agonist and antagonists
US7378428B2 (en) * 2002-01-31 2008-05-27 Ono Pharmaceutical Co., Ltd. Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient
US20050137251A1 (en) * 2002-03-18 2005-06-23 Aaron Garzon Dexanabinol and dexanabinol analogs regulate inflammation related genes
CA2496164C (en) * 2002-08-23 2010-11-09 Chiron Corporation Benzimidazole quinolinones and uses thereof
SE0300010D0 (sv) * 2003-01-07 2003-01-07 Astrazeneca Ab Novel Compounds
US20060172019A1 (en) * 2003-03-07 2006-08-03 Ralston Stuart H Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
WO2005012256A1 (en) * 2003-07-22 2005-02-10 Astex Therapeutics Limited 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
US7745476B2 (en) * 2004-01-30 2010-06-29 Solvay Pharmaceuticals B.V. 1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
TW200533657A (en) * 2004-02-17 2005-10-16 Esteve Labor Dr Substituted pyrazoline compounds, their preparation and use as medicaments
ITMI20041033A1 (it) * 2004-05-24 2004-08-24 Neuroscienze S C A R L Composti farmaceutici
WO2006044556A2 (en) * 2004-10-14 2006-04-27 Galileo Pharmaceuticals, Inc. Dual inhibitors of lipoxygenase for treating diabetes
WO2006045799A2 (en) * 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions

Also Published As

Publication number Publication date
EP1757587A1 (de) 2007-02-28
ES2372307T3 (es) 2012-01-18
PE20070246A1 (es) 2007-05-30
TW200745043A (en) 2007-12-16
US20070015810A1 (en) 2007-01-18
EP1910299A1 (de) 2008-04-16
WO2007009695A1 (en) 2007-01-25
EP1910299B1 (de) 2011-09-07

Similar Documents

Publication Publication Date Title
ATE523495T1 (de) Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
BRPI0507801A (pt) compostos de azetidina substituìda, processo para a preparação de compostos de azetidina substituìda, medicamento e uso de pelo menos um composto de azetidina substituìda
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
DOP2006000141A (es) Derivados de oxindol
BRPI0507790A (pt) composto de pirazolina substituìda, processo para a sua manufatura, medicamentos e seus usos
WO2008043544A8 (en) Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
ECSP045353A (es) Derivados de benzoxazinona, su preparación y aplicación como medicamentos
CY1111022T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
UY31346A1 (es) Compuestos que tienen actividad en el receptor m1 y sus usos en medicina
ATE529415T1 (de) Nitrosubstituierte phenylpiperazinverbindungen, deren herstellung und deren verwendung in medikamenten
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
DE602005005967D1 (de) Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament
MX2008011020A (es) Compuestos de receptor sigma.
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
WO2010031708A3 (en) Ortho-aminoanilides for the treatment of cancer
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
MX2008013477A (es) Compuestos biciclicos de tetrahidropirrol.
WO2006138589A3 (en) Opioid receptor ligands
ATE499099T1 (de) Substituierte tetrahydro- chinolinsulfonamidverbindungen, ihre herstellung und ihre verwendung als medikamente
MX2007010841A (es) 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties